Compare NBTX & SONO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NBTX | SONO |
|---|---|---|
| Founded | 2003 | 2002 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2018 | 2018 |
| Metric | NBTX | SONO |
|---|---|---|
| Price | $32.60 | $18.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $54.24 | $18.63 |
| AVG Volume (30 Days) | 136.4K | ★ 1.5M |
| Earning Date | 09-24-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.77 |
| Revenue | N/A | ★ $1,443,276,000.00 |
| Revenue This Year | N/A | $6.93 |
| Revenue Next Year | $50.69 | $6.75 |
| P/E Ratio | ★ N/A | $24.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.14 | $12.44 |
| 52 Week High | $57.14 | $19.82 |
| Indicator | NBTX | SONO |
|---|---|---|
| Relative Strength Index (RSI) | 58.72 | 62.55 |
| Support Level | $30.73 | $14.37 |
| Resistance Level | $35.17 | N/A |
| Average True Range (ATR) | 1.84 | 0.77 |
| MACD | 0.56 | 0.06 |
| Stochastic Oscillator | 72.25 | 86.26 |
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.